European Archives - Page 314 of 821 - European Medical Journal

Continue
1 Mins
27th November 2020

Sotagliflozin Associated with Reduced Risk of Cardiovascular Events

SOTAGLIFLOZIN is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that may reduce the risk of urgent medical care for heart failure, hospitalisation…
27th November 2020

Are We Virtually There Yet? Part 2 of 2

This two-part webinar features experts who have been on the leading edge of technology in medicine and share their thoughts on where telemedicine was, where it is now and where it is going.

Talking to Arun Mahtani

Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.
23rd November 2020

EMJ Podcast: Challenges in Achieving and Maintaining Remission in ANCA-associated Vasculitis

This episode, sponsored by Vifor pharma, provides an overview of the current challenges in achieving remission for patients with ANCA-associated vasculitis.
Microbiol & Infect Dis CP
11 Mins
23rd November 2020

Primer on the Pathogenesis of Severe COVID-19: Part Two

In Part One of this narrative review examining the pathogenesis of severe coronavirus disease (COVID-19), the author addressed the mechanism by which the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus subverts the innate immune response while remaining largely invulnerable to its effector functions…
1 Mins
20th November 2020

Gut Microbiota Molecule Linked to Reduced Metformin Response

DYSBIOSIS of the gut microbiota is now recognised to have significant effects on the health of an individual, with changes in metabolism linked to diabet…
1 Mins
20th November 2020

Diabetes and Hypertension May Increase risk of Neurological Complications in Patients with COVID-19

NEUROLOGICAL complication risk in patients with coronavirus disease (COVID-19) may be increased in those with a history of hypertension and Type 2…
20th November 2020

EMJ Podcast: Antibiotics in India

This week, Jonathan sits down with Professor Sumanth Gandra, Assistant Professor, Washington University School of Medicine, to discuss antimicrobial resistance in India.

Talking to Kumaran Krishnan

Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.
Int Cardiology 8.1 2020 feature image
November 2020

EMJ Interventional Cardiology 8.1 2020

EMJ Interventional Cardiology discusses geographic disparities in stroke care and considers how interventional cardiologists can help to improve equality of access to high-quality stroke care. Read these insights, and more peer-reviewed research, feature articles, and interviews in this latest issue.